813 results match your criteria: "MN (K.S.); Université Paris Descartes[Affiliation]"
Nat Med
January 2025
BioNTech US, Cambridge, MA, USA.
New treatment approaches are warranted for patients with advanced melanoma refractory to immune checkpoint blockade (ICB) or BRAF-targeted therapy. We designed BNT221, a personalized, neoantigen-specific autologous T cell product derived from peripheral blood, and tested this in a 3 + 3 dose-finding study with two dose levels (DLs) in patients with locally advanced or metastatic melanoma, disease progression after ICB, measurable disease (Response Evaluation Criteria in Solid Tumors version 1.1) and, where appropriate, BRAF-targeted therapy.
View Article and Find Full Text PDFAudiol Res
December 2024
Division of Audiology, Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN 55902, USA.
Background/objectives: Adult hearing-impaired patients qualifying for cochlear implants typically exhibit less than 60% sentence recognition under the best hearing aid conditions, either in quiet or noisy environments, with speech and noise presented through a single speaker. This study examines the influence of deep neural network-based (DNN-based) noise reduction on cochlear implant evaluation.
Methods: Speech perception was assessed using AzBio sentences in both quiet and noisy conditions (multi-talker babble) at 5 and 10 dB signal-to-noise ratios (SNRs) through one loudspeaker.
Simul Healthc
December 2024
ASPE President, 2024-2025, Past ASPE Grants & Research Committee Chair, Executive Director, M Simulation, Associate Professor, Medicine, University of Minnesota (L.C.), Minneapolis, MN; Senior Postdoctoral Fellow, Honorary Lecturer, RCSI SIM Centre for Simulation Education and Research (A.D.), Dublin, Ireland; Assistant Dean for IPE, School of Health Sciences, Springfield College (M.E.), Springfield, MA; Past ASPE Grants & Research Committee Chair, Communication Matters: INESRA, Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto, Scientist, The Wilson Centre for Research in Education, University of Toronto and University Health Network (N.M.), Toronto, Canada; Past ASPE Grants & Research Committee Chair, Associate Professor Emeritus, OB/GYN, Director of Simulation Education and Operations (ret.), Clinical Simulation Laboratory, University of Vermont (C.N.), Burlington, VT; ASPE Past President, 2008-2009, Founding Director, Simulation and Clinical Skills Center, Chair, Interprofessional Education Committee, Faculty, Department of Community and Family Medicine, Howard University (T.O.), Washington, DC; Interprofessional & Simulation Educator, Baycrest Academy for Research and Education at Baycrest Centre for Geriatric Care (C.S.), Toronto, Canada; Past ASPE Grants & Research Committee Chair, Assistant Dean, Educational Affairs, Professor, Department of Internal Medicine, Distinguished Teaching Professor, University of Texas Medical Branch (K.S.), Galveston, TX; ASPE Grants & Research Committee Chair, 2024-2025, Associate Director of Educational Measurement Research and Development, Office of Consultation & Research in Medical Education, Clinical Assistant Professor, Department of Family Medicine, Carver College of Medicine, University of Iowa (K.X.), Iowa City, IA; and Professor of Simulation Education in Healthcare, School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University (D.N.), Clayton, Australia.
Materials (Basel)
November 2024
Institute of Technology, University of the National Education Commission (UKEN), ul. Podchorążych 2, 30-084 Krakow, Poland.
This study investigates the influence of cooling rates on the microstructure and phase transformations of the high-entropy alloy CrMnFeCoNiP. The alloy was synthesized via arc melting and subjected to three cooling conditions: slow cooling (52 K/s), accelerated cooling after a short electric arc pulse (3018 K/s), and rapid quenching (10⁵-10⁶ K/s) using the melt-spinning method. The microstructures were characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and Mössbauer spectroscopy.
View Article and Find Full Text PDFJ Genet Eng Biotechnol
December 2024
Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India.
The measurement of micronucleus (MN) in the cytokinesis-block arrested binucleated cells has been extensively used as a biomarker in many radiation biology applications in specific biodosimetry. Following radiation casualties, medical management of exposed individuals begins with triage and biological dosimetry. The cytokinesis blocked micronucleus (CBMN) assay is the alternate for the gold standard dicentric chromosome assay in radiation dose assessment.
View Article and Find Full Text PDFNeurooncol Adv
November 2024
Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
Cell Rep Med
December 2024
Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address:
Hepatic steatosis is a central phenotype in multi-system metabolic dysfunction and is increasing in parallel with the obesity pandemic. We use a translational approach integrating clinical phenotyping and outcomes, circulating proteomics, and tissue transcriptomics to identify dynamic, functional biomarkers of hepatic steatosis. Using multi-modality imaging and broad proteomic profiling, we identify proteins implicated in the progression of hepatic steatosis that are largely encoded by genes enriched at the transcriptional level in the human liver.
View Article and Find Full Text PDFN Engl J Med
December 2024
From Alexandra General Hospital, National and Kapodistrian University of Athens, Athens (M.A.D.); Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC (P.M.V.); Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo (F.S.); Tel-Aviv Sourasky (Ichilov) Medical Center and Tel Aviv University, Tel Aviv, Israel (Y.C.C.); Clínica Medica São Germano, São Paulo (V.H.); Cross Cancer Institute, University of Alberta, Edmonton, Canada (I. Sandhu); Kent and Canterbury Hospital, Canterbury, United Kingdom (J.L.); Perth Blood Institute, Murdoch University, Perth, WA, Australia (R.I.B.); Japanese Red Cross Medical Center, Tokyo (K.S.); Ogaki Municipal Hospital, Ogaki City, Japan (H.K.); Albert Schweitzer Hospital, Dordrecht, the Netherlands (M.-D.L.); Ankara University, Ankara, Turkey (M.B.); Washington University School of Medicine, St. Louis (K.S.-G.); Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona (A.O.); South Pest Central Hospital, National Institute for Hematology and Infectious Diseases, Budapest, Hungary (G.M.); Hospital Alemán, Buenos Aires (G.G.); Jessa Hospital, Hasselt, Belgium (K.T.); Charles University and General Hospital, Prague, Czech Republic (I. Spicka); Rigshospitalet, University of Copenhagen, Copenhagen (A.K.M.); SSD Clinical Trials in Oncol-ematologia e Mieloma Multiplo, AOU Città della Salute e della Scienza di Torino, Turin, Italy (S.B.); Medical Unit Hematology, Karolinska University Hospital, Stockholm (K.U.); Institute of Hematology and Transfusion Medicine, Warsaw, Poland (B.P.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.M.); University of Washington and Fred Hutchinson Cancer Center, Seattle (A.J.C.); University Hospital Hôtel-Dieu, Nantes, France (P.M.); University Hospital of Salamanca, IBSAL, and Cancer Research Center, IBMCC, Salamanca, Spain (M.-V.M.); GMMG Study Group at University Hospital Heidelberg, Internal Medicine V, Heidelberg, Germany (H.G.); Genmab US, Plainsboro, NJ (T.A.); Janssen Research and Development, Shanghai, China (L.S., L.L.); Janssen Scientific Affairs, Horsham, PA (A.C.); Janssen Research and Development, Raritan, NJ (E.G.K., R.M.D.); Janssen Research and Development, Beerse, Belgium (E.R.); Janssen Research and Development, Spring House, PA (R.C.); and Mayo Clinic, Rochester, MN (S.V.R.).
Background: Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high-risk smoldering multiple myeloma, a precursor disease of active multiple myeloma for which no treatments have been approved.
Methods: In this phase 3 trial, we randomly assigned patients with high-risk smoldering multiple myeloma to receive either subcutaneous daratumumab monotherapy or active monitoring.
Nat Rev Drug Discov
December 2024
INTREPID Alliance, Cambridge, MA, USA.
Chem Biol Interact
November 2024
Molecular Biomedicine Laboratory, Postgraduate Department of Studies and Research in Biotechnology, Sahyadri Science College, Kuvempu University, Shivamogga, 577203, Karnataka, India. Electronic address:
An Acad Bras Cienc
November 2024
Universidade Federal de Lavras, Departamento de Ciência do Solo, Trevo Rotatório Professor Edmir Sá Santos, s/n, Caixa Postal 3037, 37203-202 Lavras, MG, Brazil.
In Brazil, most of cereal production is concentrated in the Cerrado which is characterized by poor soils. Thus, the soil fertility management is important for suitable use of Cerrado's soils. After 40 years of increasing use of Cerrado for agricultural purposes, this work aimed to evaluate the soil fertility of a representative area known as Triângulo Mineiro and Alto Paranaíba (TMAP) mesoregion.
View Article and Find Full Text PDFLeuk Res
November 2024
Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA.
Myelodysplastic syndromes (MDS) are associated with anemia and the need for blood transfusions. In clinical trials, luspatercept reduced transfusion dependency among patients with lower-risk MDS. This United States (US) study describes real-world clinical outcomes pre- and post-luspatercept initiation among patients with MDS.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
January 2025
From the Department of Neurology (F.P., C.O., P.S., M.N., K.R.), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Institute for Experimental Immunology (D.W., T.L., K.S., E.G.-G.), affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Luebeck; and Molecular Neuroimmunology Group (B.W., S.J.), Department of Neurology, University of Heidelberg, Germany.
Antibiotics (Basel)
October 2024
PerioTrap Pharmaceuticals GmbH, Weinbergweg 22, 06120 Halle (Saale), Germany.
Adjunctive treatment of periodontitis lacks solutions which allow for enough time for wound healing in the periodontal pockets by avoiding fast re-colonization. Such a solution might be an antibiotic-containing formulation with a controlled release over a period of weeks. Here, a recently described minocycline-containing approach is qualified for further clinical development by focusing on proof-of-concept, systemic burden, resistance development, and degradation studies.
View Article and Find Full Text PDFInt J Hematol
November 2024
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Japan.
Luspatercept has shown durable clinical efficacy for the treatment of anemia in transfusion-dependent patients with lower-risk myelodysplastic syndromes (LR-MDS). We report the results of a prespecified primary analysis of a phase 2 trial of luspatercept in non-transfusion-dependent (NTD) Japanese patients with anemia due to LR-MDS. Luspatercept (starting dose 1.
View Article and Find Full Text PDFRadiographics
December 2024
From the Department of Diagnostic Radiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, L340, Portland, OR 97239 (L.K.S., D.B., N.M.); Bristol Haematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom (A.C.); and Department of Radiology, Charing Cross Hospital, Imperial College Health Care NHS Trust, London, United Kingdom (T.D.B., M.N., A.E.).
Prostate cancer is a leading cause of cancer-related mortality in men, with metastatic castration-resistant prostate cancer presenting a substantial treatment challenge. The authors focuse on prostate-specific membrane antigen (PSMA) radiotheranostics, particularly lutetium 177 (Lu)-PSMA radioligand therapy, as an emerging treatment modality for metastatic castration-resistant prostate cancer. The U.
View Article and Find Full Text PDFCephalalgia
November 2024
Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Background: Medication overuse headache is a prevalent secondary headache due to the overuse of analgesics, mainly over-the-counter analgesics. Over-the-counter analgesics have been associated with disrupted male endocrinology, while the effects on female endocrinology remain nearly unknown. The aim was to understand the effect of long-term analgesic exposure in females with medication overuse headache on Anti-Müllerian hormone, a surrogate measure of female fertility.
View Article and Find Full Text PDFFertil Steril
November 2024
King's Fertility, Fetal Medicine Research Institute, London, United Kingdom; Faculty of Life Sciences & Medicine, Department of Women's and Children's Health, King's College London, London, United Kingdom.
Neurology
December 2024
From the Department of Neurology (E. Wilson), Cincinnati Children's Hospital, OH; Department of Neurology (E. Wilson, M.P.G., L.A.B.), Boston Children's Hospital, MA; Department of Pediatric Neurology (E. Wilson, K.C., T.C.), Massachusetts General Hospital, Boston; Department of Pediatrics (H.D.M., B.J.B., M.W., T.C.C., J.W.R.), University of Utah, Salt Lake City; Department of Neurology (M. Rodriguez, J.-M.T.), Mayo Clinic, Rochester, MN; Department of Neurology (M. Rensel, A.W.A.), Cleveland Clinic, OH; Department of Neurology (L.B.K.), New York University Medical Center, NY; Department of Neurology (T.E.L., K.S.F., N.M.S.), Texas Children's Hospital, Houston; Department of Neurology (T.L.S.), Children's Hospital Colorado, Aurora; Department of Neurology (S.S.M.), Washington University in St. Louis, MO; Department of Neurology (E. Waubant, A.V.), UCSF Weill Institute for Neurosciences, University of California San Francisco; and Department of Neurology (Y.S.W., J.M.N.), University of Alabama at Birmingham.
Nutrients
October 2024
Innovative Research Institute, Morinaga Milk Industry Co., Ltd., 1-83, 5-Chome, Higashihara, Zama 252-8583, Kanagawa, Japan.
Probiotics, particularly those native to the gut microbiota, have a profound influence on the gut environment. In this study, we conducted a randomized placebo-controlled, double-blind, parallel-group comparison trial to investigate the effects of BB536 ( BB536) on the fecal microbiota and metabolite compositions in healthy individuals. We compared the effects of fermented milk produced solely with and (placebo group) and fermented milk supplemented with BB536 (BY group).
View Article and Find Full Text PDFEnviron Monit Assess
November 2024
CSIR-National Physical Laboratory, Dr. K. S. Krishnan Road, New Delhi, 110012, India.
The present study is focused on investigating the heavy/toxic metals (Al, Ni, Cr, Pb, Cu, As, Mn, and Zn) of PM and assessing their associated human health risks. During the study period (July 2022 to July 2023), the PM samples were collected from two distinct sites in Faridabad (92 samples from site 1 and 85 samples from site 2). In this study, the US EPA's Risk Assessment Guidance for Superfund (RAGS) was followed to evaluate the human health risk associated with PM-bound heavy elements.
View Article and Find Full Text PDFNature
December 2024
Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Nat Commun
November 2024
Department of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Circulation
November 2024
Institute of Sport Exercise and Health, Division of Surgery and Interventional Sciences, University College London, United Kingdom. (J.M.B., M.H.).
Background: Blood pressure (BP)-lowering effects of structured exercise are well-established. Effects of 24-hour movement behaviors captured in free-living settings have received less attention. This cross-sectional study investigated associations between a 24-hour behavior composition comprising 6 parts (sleeping, sedentary behavior, standing, slow walking, fast walking, and combined exercise-like activity [eg, running and cycling]) and systolic BP (SBP) and diastolic BP (DBP).
View Article and Find Full Text PDF